US Capital Global has structured and advised on $10.4 billion in debt and equity financings for technology businesses worldwide.
At US Capital Global, our Technology Finance team works with visionary companies and forward-looking investors to advance the next generation of innovation. The team brings deep expertise across artificial intelligence, enterprise and application software, FinTech, HealthTech and MedTech, biotechnology, and communications infrastructure, including hardware systems, semiconductors, and chip design.
Coverage also extends to emerging technologies such as blockchain, IoT, Web3, cybersecurity, autonomous systems, digital twins, advanced manufacturing, and supply chain technologies. Through customized capital and advisory services, US Capital Global supports innovation and long-term value creation.
“US Capital Global has earned a reputation as an innovator in technology finance,” said Jeffrey Sweeney, Founder and Chairman of US Capital Global. “We have provided and advised on $10.4 billion in financing for companies across the technology sector. Our team understands the pace, complexity, and capital demands of this space, and we specialize in delivering flexible, strategic financing solutions to support growth and innovation.”
Click on the tiles below for further details about these selected transactions.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
To learn more about how your business can secure the funding it needs, email Jeffrey Sweeney, Founder and Chairman, at info@uscapital.com.
Closed transactions include all transactions advised, arranged, syndicated, structured, and/or funded by affiliated entities within the US Capital Group, both in the United States and abroad. Securities offered through US Capital Global Securities LLC (“USCGS”) the FINRA-member, SEC-registered broker-dealer division of US Capital Global. USCGS or its affiliates may provide advice to, be compensated by, may have other business relationships with, or may from time to time acquire, hold, or sell a position in the securities of, the companies mentioned herein. Private debt and equity investments are not suitable for all investors, are generally illiquid, offer no guarantee of returns, and subject investors to possible loss of principal. Any offer or solicitation shall be made only pursuant to the confidential private placement memorandum. View USCGS’ Form CRS at https://www.uscapglobalsecurities.com/crs.html.
Download a PDF of this Press Release
This page highlights US Capital Global’s Technology Finance activity, stating the firm has structured and advised on $10.4 billion in debt and equity financings for technology businesses worldwide.
The page states the Technology Finance team works with companies and investors to support innovation through customized capital and advisory services.
The page lists coverage including artificial intelligence, enterprise and application software, FinTech, HealthTech and MedTech, biotechnology, and communications infrastructure (including hardware systems, semiconductors, and chip design).
The page states coverage extends to emerging technologies such as blockchain, IoT, Web3, cybersecurity, autonomous systems, digital twins, advanced manufacturing, and supply chain technologies.
Jeffrey Sweeney, Founder and Chairman, is quoted stating that US Capital Global has earned a reputation as an innovator in technology finance and has provided and advised on $10.4 billion in financing for companies across the technology sector.
Yes. The page includes an “Example Transactions” section and invites readers to click the transaction tiles for further details.
The page invites businesses to email info@uscapital.com to learn more about securing funding.
Yes. The page includes disclosures about affiliated entities within the US Capital Group, notes that securities are offered through US Capital Global Securities LLC (USCGS), a FINRA-member, SEC-registered broker-dealer, and states that any offer or solicitation is made only pursuant to a confidential private placement memorandum.